Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Corporate Update
03 May 2023 - 06:01AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced it will report its first
quarter 2023 financial and operating results after the close of
U.S. financial markets on Tuesday, May 9, 2023.
Conference Call/Webcast
Information:
Date: |
Tuesday, May 9, 2023 |
Time: |
4:30 pm Eastern Time (1:30 pm Pacific Time) |
Dial-In: |
(800) 715-9871 or (646) 307-1963 for international callers |
Conference ID: |
4092363 |
A live audio webcast will be available on the
“Investors” section of Xenon's website and posted for replay
following the event. The above listed dates and times are subject
to change.
About Xenon Pharmaceuticals
Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need,
with a focus on epilepsy. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi
RegtsXenon Pharmaceuticals Inc.Phone: 604.484.3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Feb 2024 to Mar 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Mar 2023 to Mar 2024